• Symposium | Optimizing outcomes before and after CAR T-cell therapy in patients with large B-cell lymphoma

  • Aug 12 2024
  • Duración: 27 m
  • Podcast

Symposium | Optimizing outcomes before and after CAR T-cell therapy in patients with large B-cell lymphoma

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • During the European Hematology Association (EHA) 2024 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint satellite symposium entitled: Sequencing immune-based therapies in B-cell malignancies. Here, the Lymphoma Hub is pleased to share a real-world patient case, real-world evidence and experience, and treatment optimization of chimeric antigen receptor (CAR) T-cell therapy in patients with large B-cell lymphoma (LBCL), presented by Ulrich Jäger, Medical University of Vienna, Vienna, AT.

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Symposium | Optimizing outcomes before and after CAR T-cell therapy in patients with large B-cell lymphoma

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles